42 results
8-K
EX-1.1
STRO
Sutro Biopharma Inc
2 Apr 24
Entry into a Material Definitive Agreement
5:10pm
of Regulation S-X and the Public Company Accounting Oversight Board (United States) (the “PCAOB”).
(q)Financial Statements. The financial statements, together
8-K
EX-1.1
STRO
Sutro Biopharma Inc
9 Feb 24
Other Events
4:27pm
and the Public Company Accounting Oversight Board (United States) (the “PCAOB”).
(n) Financial Statements. The financial statements, together with the related
8-K
STRO
Sutro Biopharma Inc
27 Nov 23
Entry into a Material Definitive Agreement
4:05pm
organization (“CMO”) to source cell-free extract solely for the products it licensed from the Company, allowing Vaxcyte to have direct oversight over
8-K
kqrb545e3xmd4082
4 Oct 23
Entry into a Material Definitive Agreement
4:31pm
PRE 14A
1vajgucri
14 Apr 23
Preliminary proxy
4:05pm
8-K
5ngnhl4 ilib8d
20 Dec 22
Entry into a Material Definitive Agreement
4:07pm